Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease. 1993

A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
Biochemistry Unit, Upjohn Laboratories, Kalamazoo, Michigan 49001.

A study has been made of the susceptibility of recombinant constructs of reverse transcriptase (RT) and ribonuclease H (RNase H) from human immunodeficiency virus type 1 (HIV-1) to digestion by the HIV-1 protease. At neutral pH, the protease attacks a single peptide bond, Phe440-Tyr441, in one of the protomers of the folded, active RT/RNase H (p66/p66) homodimer to give a stable, active heterodimer (p66/p51) that is resistant to further hydrolysis (Chattopadhyay, D., et al., 1992, J. Biol. Chem. 267, 14227-14232). The COOH-terminal p15 fragment released in the process, however, is rapidly degraded by the protease by cleavage at Tyr483-Leu484 and Tyr532-Leu533. In marked contrast to this p15 segment, both p66/p51 and a folded RNase H construct are stable to breakdown by the protease at neutral pH. It is only at pH values around 4 that these latter proteins appear to unfold and, under these conditions, the heterodimer undergoes extensive proteolysis. RNase H is also hydrolyzed at low pH, but cleavage takes place primarily at Gly436-Ala437 and at Phe440-Tyr441, and only much more slowly at residues 483, 494, and 532. This observation can be reconciled by inspection of crystallographic models of RNase H, which show that residues 483, 494, and 532 are relatively inaccessible in comparison to Gly436 and Phe440. Our results fit a model in which the p66/p66 homodimer exists in a conformation that mirrors that of the heterodimer, but with a p15 segment on one of the protomers that is structurally disordered to the extent that all of its potential HIV protease cleavage sites are accessible for hydrolysis.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
September 1994, Protein engineering,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
April 1990, Virology,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
March 1995, The Journal of biological chemistry,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
February 1996, Biological chemistry Hoppe-Seyler,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
February 2000, Chemical & pharmaceutical bulletin,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
January 2012, Chemical & pharmaceutical bulletin,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
January 1991, FEBS letters,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
November 2009, Antimicrobial agents and chemotherapy,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
July 1991, Biochemistry,
A G Tomasselli, and J L Sarcich, and L J Barrett, and I M Reardon, and W J Howe, and D B Evans, and S K Sharma, and R L Heinrikson
November 2000, Nature medicine,
Copied contents to your clipboard!